Kelly D. Stone, M.D., Ph.D.Building 10, Room 12C10310 Center DriveBethesda, MD 20892-1899Phone: 301-435-0993Fax: email@example.com
Director, Allergy and Immunology Clinical Fellowship Program
Dr. Stone is the program director of the Allergy and Immunology Clinical Training Program.
Dr. Stone serves as a principal investigator on two protocols to support laboratory interests in the genetics and mechanisms of allergic inflammation in atopic dermatitis, severe atopic diseases, genetic disorders with features of allergic inflammation, and immunodeficiency diseases. He serves as a staff clinician working closely with the Allergic Inflammation Unit and the Mast Cell Biology Section of the Laboratory of Allergic Diseases (LAD), with a major interest in the advancement of research and clinical care for children with atopic dermatitis and other allergic and immunologic diseases.
Kelly Stone and an NIAID research team have found that wet wrap therapy combined with education on long-term skin care can dramatically improve the lives of children with severe eczema.
back to top
Dr. Stone received his M.D. and Ph.D. in molecular and cell biology from the University of Maryland; completed residency training in pediatrics at the Children’s National Medical Center in Washington, DC; and completed fellowship training in allergy and immunology at Children’s Hospital Boston. He served on the faculty in the department of pediatrics at Harvard Medical School and Children’s Hospital Boston and at Children’s National Medical Center and George Washington University. He joined the Laboratory of Allergic Diseases in 2007, where he serves as the director of the National Institutes of Health (NIH) Clinical Center Allergy and Immunology Clinical Fellowship Program, as a staff clinician in LAD, and as director of the NIH Clinical Center Allergy and Immunology Consultation Service. Dr. Stone is a Fellow of the American Academy of Allergy, Asthma & Immunology and American Academy of Pediatrics and a member of the Clinical Immunology Society.
Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S73-80.
Gruchalla RS, Sampson HA, Matsui E, David G, Gergen PJ, Calatroni A, Brown M, Liu AH, Bloomberg GR, Chmiel JF, Kumar R, Lamm C, Smartt E, Sorkness CA, Steinbach SF, Stone KD, Szefler SJ, Busse WW. Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. J Allergy Clin Immunol. 2009 Aug;124(2):213-21.
Stone KD, Feldman HA, Huisman C, Howlett C, Jabara HH, Bonilla FA. Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency. Clin Immunol. 2009 Apr;131(1):41-9.
Stone KD, Prussin C. Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. Clin Exp Allergy. 2008 Dec;38(12):1858-65.
Shen W, Stone K, Jales A, Leitenberg D, Ladisch S. Inhibition of TLR activation and up-regulation of IL-1R-associated kinase -M expression by exogenous gangliosides. J Immunol. 2008 Apr 1;180(7):4425-32.
Visit PubMed for a complete publication listing.
Last Updated September 25, 2012